In these difficult times, we’ve made a number of our coronavirus articles free for all readers. To get all of HBR’s content delivered to your inbox, sign up for the Daily Alert newsletter.

What would you do if you found $250 million in your bank account—money you were perfectly entitled to, but felt uncomfortable keeping? That’s roughly the situation that faced Javier Rodriquez, CEO of DaVita, a 65,000-employee chain of kidney treatment centers. His company received nearly $250 million from the Health Care Enhancement Act, a part of the U.S. government relief package enacted in response to the pandemic. Unlike the Payroll Protection Program, to which companies must apply (and which some large companies have been criticized for accessing), the health care program delivers the money to qualifying companies—without an application.